Lower brain glutamate is associated with cognitive deficits in HIV patients: a new mechanism for HIV-associated neurocognitive disorder - sprookjes - yvandenbroek - TriplyDB

Lower brain glutamate is associated with cognitive deficits in HIV patients: a new mechanism for HIV-associated neurocognitive disorder

Lower brain glutamate is associated with cognitive deficits in HIV patients: a new mechanism for HIV-associated neurocognitive disorder

http://www.wikidata.org/entity/Q34257820

about

HIV-associated neurocognitive disorder--pathogenesis and prospects for treatment Role of neuroimaging in HIV-associated neurocognitive disorders HIV and aging: effects on the central nervous system Vulnerability of welders to manganese exposure--a neuroimaging study Neural correlates of working memory training in HIV patients: study protocol for a randomized controlled trial.Lower cognitive reserve in the aging human immunodeficiency virus-infected brain.Impact of apolipoprotein E ε4 and HIV on cognition and brain atrophy: antagonistic pleiotropy and premature brain aging.Magnetic resonance spectroscopy to assess neuroinflammation and neuropathic pain.Neuroimaging of HIV-associated neurocognitive disorders (HAND)Glutamate metabolism and HIV-associated neurocognitive disorders.Effects of APOE ε4, age, and HIV on glial metabolites and cognitive deficits A peripheral monocyte interferon phenotype in HIV infection correlates with a decrease in magnetic resonance spectroscopy metabolite concentrations.Brain Abnormalities in HIV and Stimulant Users: Interventions and Prevention Neuroimaging studies of the aging HIV-1-infected brain Cerebral metabolite changes prior to and after antiretroviral therapy in primary HIV infection Longitudinal cerebral metabolic changes in pig-tailed macaques infected with the neurovirulent virus SIVsmmFGb.Form follows function: astrocyte morphology and immune dysfunction in SIV neuroAIDS HIV infection is associated with attenuated frontostriatal intrinsic connectivity: a preliminary study Molecular mechanism of HIV-1 Tat interacting with human dopamine transporter.Independent effects of HIV, aging, and HAART on brain volumetric measures.Case control study: magnetic resonance spectroscopy of brain in HIV infected patients.Pilot Assessment of Brain Metabolism in Perinatally HIV-Infected Youths Using Accelerated 5D Echo Planar J-Resolved Spectroscopic Imaging.Prefrontal dopaminergic and enkephalinergic synaptic accommodation in HIV-associated neurocognitive disorders and encephalitis.Edited 1 H magnetic resonance spectroscopy in vivo: Methods and metabolites.Phase-adjusted echo time (PATE)-averaging 1 H MRS: application for improved glutamine quantification at 2.89 T.Integrated (18)F-fluorodeoxyglucose positron emission tomography magnetic resonance imaging ((18)F-FDG PET/MRI), a multimodality approach for comprehensive evaluation of dementia patients: A pictorial essay.In vivo glutamate measured with magnetic resonance spectroscopy: behavioral correlates in aging.Neuropsychological function and cerebral metabolites in HIV-infected youth.Expression of ephrin receptors and ligands in postmortem brains of HIV-infected subjects with and without cognitive impairment.Neuropathogenesis of Chikungunya infection: astrogliosis and innate immune activation Cerebrospinal fluid and neuroimaging biomarker abnormalities suggest early neurological injury in a subset of individuals during primary HIV infection.Cannabinoids Occlude the HIV-1 Tat-Induced Decrease in GABAergic Neurotransmission in Prefrontal Cortex Slices.Neuropsychological, Neurovirological and Neuroimmune Aspects of Abnormal GABAergic Transmission in HIV Infection.HIV gp120 sequence variability associated with HAND in Hispanic Women.Regional variations of antioxidant capacity and oxidative stress responses in HIV-1 transgenic rats with and without methamphetamine administration.Neurometabolite Alterations Associated With Cognitive Performance in Perinatally HIV-Infected Children.β-Catenin signaling positively regulates glutamate uptake and metabolism in astrocytes.Decreased MEG beta oscillations in HIV-infected older adults during the resting state.Neuroimaging of rapidly progressive dementias, part 2: prion, inflammatory, neoplastic, and other etiologies.Widespread neuronal damage and cognitive dysfunction in spinocerebellar ataxia type 3.

P2860

Q26766448-35662951-5A27-4E67-8EC2-2334578FD6FB Q26852705-F7F31578-7401-4DBF-9597-0146C296D83B Q27025018-5F271174-A5A4-4DF3-B84E-54C54FAE6C50 Q28394946-6C2CC546-9582-49D0-A14D-CCFACF809E13 Q30391907-3734C191-0B45-400D-BB80-89960A3543EA Q30440212-9F5E89A6-E7F6-49DB-BE0F-61133B8F6DB1 Q30462497-EF6B8B2F-33F9-4A43-BCCC-2505189CAE1B Q30624704-F69E6AF2-7FBB-4A1D-9B53-26C7A18B08A0 Q30854917-B6FB9A14-8580-4CE3-BD96-84492ABD6DF0 Q33903612-556B47B8-60EC-446A-A29D-E99AF0BE59E9 Q33961790-DFF543C1-511E-4E0B-8901-367F7D422843 Q33998110-4E873C30-6B5E-4804-B60F-D75EB34CBBE4 Q34247745-E05A1D51-17A8-4281-B81F-FC0C16E0E586 Q34288457-5C52CA55-74C9-41D5-ACEE-07E28B7C9112 Q34466521-86A38F3A-38B2-4E4B-AB5B-4355B767388A Q34714799-79ACFF8D-F601-4593-ADD6-2A9F51E87DBC Q35016863-30616A82-B819-4315-8DB8-DF56119155AB Q35449960-2665D2BF-ACE3-4D9E-ACE8-2EF03EF7369B Q35450098-A7B90305-9ADD-42E7-AF20-96E0F5E09AD4 Q35827867-CA130ED6-66F1-458B-9B76-C76C355A213C Q36074026-A7A6112F-DE2B-4547-A54B-D8492F3C999E Q36131217-F261DA5B-CBF5-4D6E-A833-CB5567AD685A Q36164951-9C6E6A0C-5206-4AC1-830B-1AE1FC259C2A Q36267156-8AAEF9F1-4891-4ECD-9230-7E93D4B5D5AC Q36311187-82AF90AA-9B28-4905-8AC1-155EDBA988A9 Q36409826-A6EC8AA6-3687-4718-A32F-F61F2EE7DD79 Q36532969-995E49D5-03C0-427A-B411-721B4DDFA440 Q36569217-482FDFFE-F702-4FA3-8094-851BECF72F1B Q36655069-1E23C558-1C5A-4D2E-A5C7-15669977008D Q36665279-DB7DA035-E908-4273-A38A-CEA78C6F5208 Q36796560-73A3D8F3-8774-47C6-B8E5-076B661E234A Q36844731-B131A0FF-5CAE-431F-8CE9-A1DF660EA351 Q36845234-BE96589F-089F-47D2-ACFC-CB7FEB51AD0D Q37042148-F205FC7D-F3BD-49B0-A7CB-B86933BFD88F Q37172356-7E0B0363-8BB2-417C-B957-D6DEA0A24FB7 Q37205326-0F23752D-85F7-44CF-B2B4-9B7A5B2B55B1 Q37246158-B672120B-F39E-4406-8446-D0C7BFEAB408 Q37552824-1D078CF5-F483-419F-9900-20AE75E46D59 Q38081869-1DDFD850-FD1A-4B21-A7E6-27DF18B10848 Q38449818-513A6D11-40F6-49E6-9447-FE69550BDD72

P2860

Lower brain glutamate is associated with cognitive deficits in HIV patients: a new mechanism for HIV-associated neurocognitive disorder

http://www.wikidata.org/entity/Q34257820

description

2010 nî lūn-bûn

@nan

2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Lower brain glutamate is assoc ...... ciated neurocognitive disorder

@ast

Lower brain glutamate is assoc ...... ciated neurocognitive disorder

@en

Lower brain glutamate is assoc ...... ciated neurocognitive disorder

@nl

type

label

Lower brain glutamate is assoc ...... ciated neurocognitive disorder

@ast

Lower brain glutamate is assoc ...... ciated neurocognitive disorder

@en

Lower brain glutamate is assoc ...... ciated neurocognitive disorder

@nl

prefLabel

Lower brain glutamate is assoc ...... ciated neurocognitive disorder

@ast

Lower brain glutamate is assoc ...... ciated neurocognitive disorder

@en

Lower brain glutamate is assoc ...... ciated neurocognitive disorder

@nl

P1433

Q34257820-17B84781-CB6E-44E7-AF48-58333BC46FDD

P1476

Q34257820-23D24AB1-534A-4343-A62B-111FC3534C85

P2093

Q34257820-25306F6F-13AB-4BD3-BB68-C542F30D210F

Q34257820-61BDF363-6BE2-499B-9C18-5739BEC1B442

Q34257820-7252E1B6-C15D-4C3A-A0C2-CA34D014C7F6

Q34257820-94CA2753-777B-42F5-99A0-03B341801AA2

P2860

Q34257820-01EC0873-FE56-41F9-8906-B7C4241E0E55

Q34257820-03429B5E-D11D-4576-8300-4E1D81BE0BBA

Q34257820-06AE1C7F-3AA5-4766-BECB-3D664EC022F8

Q34257820-114E258E-E24E-44D2-8A62-6AD6B011236F

Q34257820-16E8E4E2-BB04-40A6-AD89-328296AC2BCF

Q34257820-1897B9C2-21D8-43F2-BD5D-827EA51E38BC

Q34257820-2602D7FD-F807-4F33-A432-DA564546919B

Q34257820-26824AB7-F998-47B5-A0CA-2F1C3E836809

Q34257820-27890644-0E36-4B65-B59C-F4A0F9B1E099

Q34257820-377EE22C-B6B7-4500-9A52-A2FCDEB493AB

P304

Q34257820-B0B69349-4859-43BC-A151-17984BDE21F5

P31

Q34257820-7AA96710-6886-47D3-95AE-829D3314C1C2

P356

Q34257820-367E6AFA-FC8F-448A-8E4E-A080632BA205

P433

Q34257820-EB00930C-2779-459D-AA90-F1DAE42C5A0F

P478

Q34257820-AEEC51A7-A4BD-45E7-91B2-B859443872AF

P50

Q34257820-0F583E8D-B797-4F67-83A6-9C94A9CD374A

P577

Q34257820-466CF3DE-2FBF-4475-9C2E-4ACDB88CA85D

P5875

Q34257820-2400B8F9-634E-4842-8E75-DF8AE3FB4EAE

P698

Q34257820-ADE2DD1D-BFEB-493D-8544-76BA22A0D495

P921

Q34257820-F2E6C7A6-551D-4927-A01B-3FD92DF45ABD

P932

Q34257820-5866031F-8C75-406B-AE40-988B56D6BC48

P356

P1433

Journal of Magnetic Resonance Imaging

P1476

Lower brain glutamate is assoc ...... ciated neurocognitive disorder

@en

P2093

Caroline S Jiang

http://www.w3.org/2001/XMLSchema#string

Helenna Nakama

http://www.w3.org/2001/XMLSchema#string

Steven Buchthal

http://www.w3.org/2001/XMLSchema#string

Thomas Ernst

http://www.w3.org/2001/XMLSchema#string

P2860

Effects of age and sex on brain glutamate and other metabolites

Neuropathology and neurodegeneration in human immunodeficiency virus infection. Pathogenesis of HIV-induced lesions of the brain, correlations with HIV-associated disorders and modifications according to treatments

TNF alpha potentiates glutamate neurotoxicity by inhibiting glutamate uptake in organotypic brain slice cultures: neuroprotection by NF kappa B inhibition

Effects of human immunodeficiency virus type 1 on astrocyte gene expression and function: potential role in neuropathogenesis

Region and tissue differences of metabolites in normally aged brain using multislice 1H magnetic resonance spectroscopic imaging

Reflections on the application of 13C-MRS to research on brain metabolism.

Bayesian analysis of neuroimaging data in FSL.

Pathways to neuronal injury and apoptosis in HIV-associated dementia.

SPECT imaging of the brain: comparison of findings in patients with chronic fatigue syndrome, AIDS dementia complex, and major unipolar depression.

Neuroprotective therapy for HIV dementia.

P304

1045-1053

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/JMRI.22366

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

32

http://www.w3.org/2001/XMLSchema#string

P50

P577

2010-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

47622464

http://www.w3.org/2001/XMLSchema#string

P698

21031507

http://www.w3.org/2001/XMLSchema#string

P921

P932

2967445

http://www.w3.org/2001/XMLSchema#string